Abstract

Long-term controversy regarding the role of angiopoietin-like protein 8 (ANGPTL8) in beta-cell proliferation and diabetes progression made it a research spotlight. Recently, the controversy was resolved. Although ANGPTL8 could not control beta-cell expansion and islet function, ANGPTL8 was still considered as a novel but atypical member in the ANGPTL family because of its unique structure and crucial effects on lipid metabolism. Besides, ANGPTL8 also participated in some other disorders such as non-alcoholic fatty liver disease and renal dysfunction. Understanding the features of ANGPTL8 may offer new diagnostic and therapeutic approaches to metabolic-related diseases. Therefore, we reviewed most recent findings about ANGPTL8 and aimed to provide an integrated picture of ANGPTL8.

Highlights

  • Angiopoietin-like proteins (ANGPTLs) are a group of secreted glycoproteins composed of eight members (ANGPTL1–8) [1]

  • Zhang et al proposed a potential mechanism to demonstrate the effects of angiopoietin-like protein 8 (ANGPTL8) on triglyceride metabolism in different nutritional states [25, 26]

  • Adipose triglyceride lipase (ATGL), a crucial enzyme involved in triglyceride hydrolysis in adipocytes, was downregulated and lipid was accumulated in adipose tissue [17]

Read more

Summary

Mengdie Luo and Daoquan Peng*

Reviewed by: Sana Siddiqui, University of California, San Francisco, United States. ANGPTL8: An Important Regulator in Metabolic Disorders. Long-term controversy regarding the role of angiopoietin-like protein 8 (ANGPTL8) in beta-cell proliferation and diabetes progression made it a research spotlight. ANGPTL8 could not control beta-cell expansion and islet function, ANGPTL8 was still considered as a novel but atypical member in the ANGPTL family because of its unique structure and crucial effects on lipid metabolism. ANGPTL8 participated in some other disorders such as non-alcoholic fatty liver disease and renal dysfunction. Understanding the features of ANGPTL8 may offer new diagnostic and therapeutic approaches to metabolic-related diseases. We reviewed most recent findings about ANGPTL8 and aimed to provide an integrated picture of ANGPTL8

INTRODUCTION
Signal peptide
Findings
MS NAFLD Pregnancy GDM
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.